Charmacy Pharmaceutical Co (HKSE:02289) Net Issuance of Debt : HK$256 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Charmacy Pharmaceutical Co's net issuance of debt for the six months ended in Dec. 2024 was HK$129 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2024 was HK$256 Mil.

Charmacy Pharmaceutical Co Net Issuance of Debt Historical Data

The historical data trend for Charmacy Pharmaceutical Co's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charmacy Pharmaceutical Co Net Issuance of Debt Chart

Charmacy Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Debt

Get a 7-Day Free Trial

77.54

168.34

-273.63

81.27

254.58

Charmacy Pharmaceutical Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Issuance of Debt	Get a 7-Day Free Trial															-118.12	156.89	-75.62	126.31	129.31

Charmacy Pharmaceutical Co Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$256 Mil.

Charmacy Pharmaceutical Co Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Charmacy Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041

Website

https://www.chmyy.com

Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes Western medicine, Chinese patent medicine, and healthcare products to downstream distributors and retail terminals while conducting dealings in the third-party logistics business of medicines and providing pharmaceutical products-related consulting services. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.

Executives

Jiangxi Pharmaceutical Investment Co., Limited	2101 Beneficial owner
Jiang Yao Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Jiang Xi Jiang Zhong Yi Yao Shang Ye Yun Ying You Xian Ze Ren Gong Si	2201 Interest of corporation controlled by you
Yao Chuanglong	2101 Beneficial owner
You Zeyan	2202 Interest of your spouse
Guang Zhou Bai Yun Shan Yi Yao Ji Tuan Gu Fen You Xian Gong Si	2201 Interest of corporation controlled by you
Guang Zhou Yi Yao Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Guang Yao Bai Yun Shan Xiang Gang You Xian Gong Si	2101 Beneficial owner
Rays Capital Partners Limited	2102 Investment manager
Ruan David Ching Chi	2201 Interest of corporation controlled by you
Asian Equity Special Opportunities Portfolio Master Fund Limited	2101 Beneficial owner
Wang Yonghui	2101 Beneficial owner

Charmacy Pharmaceutical Co Headlines

No Headlines